Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1982 May;36(2):841–843. doi: 10.1128/iai.36.2.841-843.1982

Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.

D D Humphrey, O M Kew, P M Feorino
PMCID: PMC351306  PMID: 6282759

Abstract

Four independent hybridoma clones have been established that produce neutralizing antibodies specific to type 1 poliovirus. Each clone produced antibody which neutralized a distinct set of type 1 test strains: (i) all 15 strains tested; (ii) the inducer strain only; (iii) predominantly wild strains; or (iv) all vaccine-related and some wild strains.

Full text

PDF
841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Flamand A., Wiktor T. J., Koprowski H. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. J Gen Virol. 1980 May;48(1):105–109. doi: 10.1099/0022-1317-48-1-105. [DOI] [PubMed] [Google Scholar]
  2. Kapsenberg J. G., Coutinho R. A., Hazendonk A. G., Ran A. B., van Wezel A. L. Epidemiological implications of the isolations and intratypic serodifferentiation of poliovirus strains in the Netherlands. Dev Biol Stand. 1981;47:293–301. [PubMed] [Google Scholar]
  3. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979 Oct;123(4):1548–1550. [PubMed] [Google Scholar]
  4. Kew O. M., Pallansch M. A., Omilianowski D. R., Rueckert R. R. Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol. 1980 Jan;33(1):256–263. doi: 10.1128/jvi.33.1.256-263.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Martin M. L., Palmer E. L. Complement-fixing antigens produced by varicella-zoster virus in tissue culture. Appl Microbiol. 1973 Sep;26(3):410–416. doi: 10.1128/am.26.3.410-413.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. NAKANO J. H., GELFAND H. M. The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin's vaccine strain. I. Standardization and evaluation of the test. Am J Hyg. 1962 May;75:363–376. doi: 10.1093/oxfordjournals.aje.a120258. [DOI] [PubMed] [Google Scholar]
  7. Nottay B. K., Kew O. M., Hatch M. H., Heyward J. T., Obijeski J. F. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology. 1981 Jan 30;108(2):405–423. doi: 10.1016/0042-6822(81)90448-7. [DOI] [PubMed] [Google Scholar]
  8. Zweig M., Heilman C. J., Jr, Rabin H., Hopkins R. F., 3rd, Neubauer R. H., Hampar B. Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2. J Virol. 1979 Nov;32(2):676–678. doi: 10.1128/jvi.32.2.676-678.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES